Evidence map›Paper›PMID 10359759›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

A small nucleolar RNA:ribozyme hybrid cleaves a nucleolar RNA target in vivo with near-perfect efficiency.

D A Samarsky, G Ferbeyre, E Bertrand, R H Singer, R Cedergren, M J Fournier

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 57 citations in OpenAlex.

  1. Aptamers, Riboswitches, and Ribozymes inLife (Basel, Switzerland) · 2021
    Review
  2. Disruption of dengue virus transmission by mosquitoes.Current opinion in insect science · 2015
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

D A SamarskyDepartment of Biochemistry and Molecular Biology, University of Massachusetts, Amherst, MA 01003, USA.
G Ferbeyre
E Bertrand
R H Singer
R Cedergren
M J Fournier
Albert Einstein College of Medicine · USCentre National de la Recherche Scientifique · FR

Funding

RNA TRANSPORT AND LOCALIZATION IN YEAST IN SITUR01GM057071 · NIGMS · YESHIVA UNIVERSITY · PI SINGER, ROBERT H · 1998 to 2019
$5.7M
BIOSYNTHESIS OF TRANSFER, 4.5S &6S RIBONUCLEIC ACIDSR01GM019351 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FOURNIER, MAURILLE J · 1985 to 2008
$3.3M
NIGMS NIH HHS GM 19351NIGMS NIH HHS GM 54887NIGMS NIH HHS GM 57051NIGMS NIH HHS R01 GM019351NIGMS NIH HHS R01 GM057071
6 · The paper itself

Abstract

A hammerhead ribozyme has been localized to the yeast nucleolus by using the U3 small nucleolar RNA as a carrier. The hybrid small nucleolar RNA:ribozyme, designated a "snorbozyme," is metabolically stable and cleaves a target U3 RNA with nearly 100% efficiency in vivo. This is the most efficient in vivo cleavage reported for a trans-acting ribozyme. A key advantage of the model substrate featured is that a stable, trimmed cleavage product accumulates. This property allows accurate kinetic measurements of authentic cleavage in vivo. The system offers new avenues for developing effective ribozymes for research and therapeutic applications.

Indexed as

Base SequenceMolecular Sequence DataRNA, CatalyticRNA, Small NuclearSaccharomyces cerevisiaeSubstrate SpecificityRNA, CatalyticRNA, Small Nuclear

Identifiers

PMID10359759
PMCPMC21962
OpenAlexW1969052855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.